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Abstract 
Background: Metabolic syndrome is a growing worldwide health problem. We evaluated the effects of wine grape 
powder (WGP), rich in antioxidants and fiber, in a rat model of metabolic syndrome induced by a high fructose diet. 
We tested whether WGP supplementation may prevent glucose intolerance and decrease oxidative stress in rats fed 
with a high fructose diet.
Methods: Male Sprague–Dawley rats weighing 180 g were divided into four groups according to their feeding pro‑
tocols. Rats were fed with control diet (C), control plus 20 % WGP (C + WGP), 50 % high fructose (HF) or 50 % fructose 
plus 20 % WGP (HF + WGP) for 16 weeks. Blood glucose, insulin and triglycerides, weight, and arterial blood pressure 
were measured. Homeostasis model assessment (HOMA) index was calculated using insulin and glucose values. A 
glucose tolerance test was performed 2 days before the end of the experiment. As an index of oxidative stress, thio‑
barbituric acid reactive substances (TBARS) level was measured in plasma and kidney, and superoxide dismutase was 
measured in the kidney.
Results: Thiobarbituric acid reactive substances in plasma and renal tissue were significantly higher when compared 
to the control group. In addition, the area under the curve of the glucose tolerance test was higher in HF fed animals. 
Furthermore, fasting blood glucose, plasma insulin levels, and the HOMA index, were also increased. WGP supple‑
mentation prevented these alterations in rats fed with the HF diet. We did not find any significant difference in body 
weight or systolic blood pressure in any of the groups.
Conclusions: Our results show that WGP supplementation prevented hyperglycemia, insulin resistance and reduced 
oxidative stress in rats fed with HF diet. We propose that WGP may be used as a supplement in human food as well.
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Background
The development of industrialized countries together 
with technological advances has produced strong social 
changes that directly affect the human lifestyle. Changes 
in diet and a sedentary lifestyle characterized by the lack 
of exercise in daily life advance in parallel with a grow-
ing number of metabolic diseases, resulting in high 
cardiovascular risk and increased morbidity and mor-
tality rate. The association of a collection of risk factors 
including hypertension, high triglycerides, low HDL cho-
lesterol, and high fasting glucose, which are linked to type 
2 diabetes, cardiovascular disease and stroke, created a 
condition called metabolic syndrome (MS). The World 
Health Organization defines MS as a prothrombotic 
state, with dyslipidemia, alteration in the metabolism 
of glucose, a sustained rise in blood pressure, abdomi-
nal obesity and a systemic pro-inflammatory state [1]. 
The metabolic syndrome has high prevalence, estimated 
between 20 and 30 % of adult worldwide population [2, 
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3]. Abdominal obesity, one of the MS features, produces 
oxidative stress. Accordingly, it has been found that an 
increased oxidative stress in abdominal adipocytes may 
increase various pro-inflammatory cytokines and fatty 
acids, which exacerbate other MS factors such as insu-
lin resistance, hypertriglyceridemia, and hypertension 
[4]. In addition, it has been demonstrated that the activ-
ity of several antioxidant enzymes decreases in humans 
with MS [5]. One of the transcription factors respon-
sible for the initiation of the antioxidant response is the 
nuclear factor E2-related factor-2 (Nrf2), which controls 
the expression of cellular phase-2 detoxifying and anti-
oxidant enzymes [6, 7]. Nrf2 induces the expression of 
several antioxidant enzymes [8–11] such as superoxide 
dismutase (SOD) to restore the imbalance of oxidative 
stress [12, 13].
Because MS involves several different factors, no 
unique pharmaceutical treatment exists to prevent or 
treat it. The best solution seems  to be to adjust lifestyle 
factors like diet and exercise. It is known that grape anti-
oxidants play a role in the reduction of the metabolic 
syndrome risk factors. Grapes contain numerous anti-
oxidants such as polyphenols, anthocyanins, flavonols 
and resveratrol. A simple way to make grape polyphenols 
part of the diet is to consume grape products. Wine grape 
pomace is an underused residue of the wine making pro-
cess. This grape by-product contains pressed skins, seeds 
and stems and accounts for about 20 % of the weight of 
the grapes used to make wine. In addition, grape pom-
ace is a rich source of polyphenols including monomeric 
and oligomeric proanthocyanidins and a diversity of 
anthocyanin glycosides [14]. Due to the abundance of 
antioxidants found in this by-product, grape pomace is 
increasingly being used to obtain functional food ingredi-
ents and as a dietary supplement [15]. Flavonoids that are 
present in grape pomace are a large group of polyphenolic 
antioxidants present in a variety of foods. Most naturally 
occurring flavonoids can induce chelation of transition 
metals, the scavenging of free radicals, and inhibition of 
radical producing enzymes [16]. In addition, it has been 
postulated that a flavonoid-rich diet can prevent several 
degenerative age-related diseases [17] and several kinds 
of cancer [18]. It can also reduce the incidence of coro-
nary heart disease [15], and chronic renal disease [19]. 
As mentioned before, it is well accepted that diets rich 
in polyphenols have health benefits, but the mechanisms 
of action of these molecules in the human body are not 
fully understood [20–22]. Wine grape powder (WGP) 
made from dried wine grape pomace, is rich in fiber and 
polyphenols. However, little is known about the potential 
effects of WGP in the oxidative state or metabolic mark-
ers of MS. Therefore, the present study was conducted 
to investigate the antioxidant and anti-insulin-resistance 
effect of WGP in an established rat model of MS induced 
by high fructose diet [23–26].
Methods
Wine grape powder
Wine grape pomace, a waste product from wine produc-
tion was obtained from a single production lot of red 
grapes (Cabernet Sauvignon, vintage 2011, Maipo Valley, 
Chile) from Concha y Toro Winery, and stored at −20 °C 
until used, for approximately 3 months. The frozen wine 
grape pomace was thawed at room temperature and dried 
in a forced air dryer at 60 °C until moisture reached less 
than 12  %. The dried pomace was grinded with a ham-
mer mill to obtain a wine grape pomace powder (WGP), 
which was packaged in double plastic bags of 20 kg. WGP 
has a high content of dietary fiber (48 %) determined by 
AOAC 991.43. The content of polyphenolic compounds 
was 41.11 ± 3.01 mg galic acid equivalent/g, determined 
by the Folin-Ciocalteu procedure [27]. WGP with a high 
antioxidant capacity of 362.9  ±  24.4  µmol TE/g, meas-
ured by the oxygen radical absorbance capacity assay 
[28].
Rats, diets, and treatment with WGP
The experimental protocols were approved by the Bio-
ethical Committee of the Faculty of Biological Sciences of 
the Pontificia Universidad Católica de Chile and were in 
accordance with the Guide for the Care and Use of Labo-
ratory Animals published by the US National Institutes 
of Health (NIH Publication No. 85-23, revised 1996). 
Male Sprague–Dawley rats (6  week old, 180  g) were 
obtained from the Faculty of Biological Sciences Animal 
Care Facility. Rats were randomly divided into 4 groups 
according to their feeding treatments: control diet-fed 
rats (C; n = 8), control diet-fed rats supplemented with 
WGP (C +  WGP; 20  % of WGP; n =  8); high-fructose 
diet-fed rats (HF; 50  % fructose, n  =  7) and high-fruc-
tose diet-fed rats supplemented with WGP (HF + WGP, 
n = 6).
Mixtures for each of the diets were prepared on an 
industrial mixer at the Molino La Estampa, Chile, using 
the proportions for each of the ingredients shown in 
Table  1. Food pellets for each of the animal diets were 
prepared daily by adding the same amount of water to a 
fraction of each of the powder mixtures.
The proximate analysis of the WGP is shown in Table 2, 
and the composition and energy provided by proteins, 
carbohydrates and fat in experimental diets is shown in 
Table 1. Animals were fed with 36 g (dry mixture) of their 
respective diets daily for 16 weeks. Rats were individually 
housed under controlled temperature, 12-h-light/dark 
cycles, consumed water ad  libitum, and were under vet-
erinarian supervision.
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Physiological and metabolic variables
All rats were continuously monitored for body weight, 
food and water intake. Blood glucose and triglycerides 
were measured using a commercial enzymatic kit and 
strips (Code Free, SD Biosensor Inc, Korea). Oral glucose 
tolerance test (GTT) was performed 2 days before the end 
of the experiment, on rats that have been food-deprived 
for 12 h. Each animal received 2 g/kg of glucose diluted 
in 2 mL of water by gavage. Rats were anesthetized with 
isofluorane 2 % in O2, and blood samples were obtained 
from the tail vein at 0  min (before glucose administra-
tion) 30, 60 and 120 min. A glucose tolerance curve was 
obtained and the trapezoidal rule was used to determine 
the area under the curve (AUC).
Arterial blood pressure measurements
Measurements of systolic arterial blood pressure was per-
formed with a non-invasive method in conscious rats, 
in a room at 25  °C, with noise and light control. These 
measurements were done using a Power Lab coupled to 
a NIBP system with pulse transducer/cuff for rat by tail 
cuff (ADInstruments, Australia). Rats were trained at least 
for 1  month before the experimental measurements. In 
separate experimental series, three rats were anesthetized 
with isofluorane 2 % in O2 and were implanted with radio-
telemetric transmitters (TA11PA, DSI, USA) in one femo-
ral artery. After surgery, rats received Ketoprofen 0.2 mg/
kg (Rhodia Merieux) and Enrofloxacin 20 mg/kg (Bayer) 
i.m. Rats were allowed to recover for 7 days prior to the 
surgery and then were fed with control, high fructose and 
high fructose +  WGP diets for 120  days. Arterial blood 
pressure was averaged from 30  min recordings, per-
formed between 9 and 10 AM every 3 days in the initial 
90 days, and then every 10 days during the last 30 days.
Blood and tissue samples
At the end of the experiment, blood samples were taken, 
and then animals were sacrificed under anesthesia (Xyla-
sine/Ketamine, 10  mg/90  mg per kg). Kidneys were 
immediately removed, frozen in liquid nitrogen and 
stored at −80 °C for later determinations. Plasma insulin 
level was determined using a rat insulin ELISA kit (EMD 
Millipore Corporation, USA), calculating the homeosta-
sis model assessment of insulin resistance (HOMA-IR), 
based on the following formula:
Oxidative stress measurement
Levels of thiobarbituric acid reactive substances (TBARS) 
in the plasma and kidneys were estimated using a previ-
ously described method [29] with slight modifications. 
100  μL of plasma or supernatant from tissue homoge-
nate were mixed with 50  μL sodium dodecyl sulphate 
(8  %w/v), 375  μL thiobarbituric acid (0.8  % w/v), and 
375 μL acetic acid (20 %v/v); and then heated for 60 min 
at 90 °C. The precipitated material was removed by cen-
trifugation, and the absorbance of the supernatant was 
determined at 532 nm. Levels of TBARS were expressed 
as malondialdehyde (MDA).




× plasma insulin (µU/mL)/405.
Table 1 Composition and  energy provide by  the experi-
mental diets
C control diet, C + WGP control diet plus 20 % wine grape powder, HF high 
fructose diet, HF + WGP high fructose diet plus 20 % wine grape powder
Compound C C + WGP HF HF + WGP
Corn flour g/100 g
Molino La Estampa, Chile
62.1 50.0 12.1 0.0
Fructose g/100 g
105321 Merck
0.0 0.0 50.0 50.0
Caseinate g/100 g
C8659 Sigma‑Aldrich
20.0 18.0 20.0 18.0
Methionine g/100 g
M9625 Sigma‑Aldrich
0.3 0.3 0.3 0.3
Corn oil g/100 g
Chef, Chile
5.0 5.0 5.0 5.0
Cellulose g/100 g
Molino La Estampa, Chile
8.1 2.2 8.1 2.2
WGP g/100 g 0.0 20.0 0.0 20.0
Mineral mixture g/100 g
AIN‑76 MP biomedicals
3.5 3.5 3.5 3.5
Vitamin mixture g/100 g
AIN‑76 MP biomedicals
1.0 1.0 1.0 1.0
Energy from fat  % 11.2 15.0 11.3 15.0
Energy from carbohydrates % 62.2 63.9 68.4 63.9
Energy from proteins % 20.3 21.1 20.3 21.1
Energy kcal/100 g 399.3 389.6 399.3 389.3
Table 2 Proximate analysis of wine grape flour
Total dietary fiber corresponds to the sum of soluble and insoluble fractions





Total dietary fiber 47.7
Soluble dietary fiber 3.5
Insoluble dietary fiber 44.2
Ash 8.4
Moisture 7.5
Energy kcal/100 g 321.8
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Electrophoresis and Western blot analysis
To determine relative levels of Nrf-2 (1:500; Santa Cruz 
Biotechnology) and mSOD (1:2000, Millipore), kidney 
homogenates were lysed in RIPA with protease inhibi-
tors (1 mg/mL aminocaproic acid, 1 mg/mL benzamidine, 
0.2 mg/mL SBTI and 3 mmol/L PMSF) and phosphatase 
inhibitors (12 μg/mL sodium orthovanadate, 4.46 mg/mL 
sodium pyrophosphate, and 4.2 mg/mL sodium fluoride). 
Lysates were centrifuged and supernatants were collected 
for Western blot analysis. Protein concentrations were 
determined by the method of Lowry [30]. Protein samples 
(100  μg) from homogenates under different treatments 
were separated by electrophoresis in 10  % SDS–poly-
acrylamide gel (SDS-PAGE). Proteins were transferred to 
a 0.45 μm PVDF membrane, which was blocked at room 
temperature with Tris pH 7.6/5  % skim milk (w/v)/BSA 
1 % (w/v). Then, the PVDF membrane was incubated over-
night at 4 °C with primary antibody, followed by incubation 
with rabbit secondary antibody conjugated to peroxidase 
(1:2000) for 2  h. Immunoreactive bands were visualized 
using a chemiluminescent reagent (Western Lightning, 
Perkin Elmer) according to the procedure described by the 
supplier and Kodak films X-LS. The bands detected were 
digitized and subjected to densitometric analysis using the 
program Image J (NIH, Washington DC, USA).
Statistical analysis
Data obtained from different groups of rats were com-
pared with each other by one-way analysis of variance 
(ANOVA) followed by a Bonferroni’s post hoc test. The 
analyses were performed with GraphPad Prism 5 soft-
ware for Windows (GraphPad Software). Results are 
expressed as mean ± standard error of the mean (SEM). 
Differences were considered significant if p ≤ 0.05.
Results
Effects of the high fructose diet on the physiological 
parameters measured in rats
High fructose diet increased glucose, triglycerides and 
insulin levels in plasma measured after 12  h of food 
deprivation, but did not induce changes in systolic arte-
rial pressure, body or heart weight (Table 3). Supplemen-
tation with WGP to the HF diet reduced the increase in 
glucose, triglycerides and insulin levels in plasma. In a 
separate experimental series, we recorded systolic and 
diastolic arterial pressure with radiotelemetry in three 
rats fed with control, high fructose and high fructose plus 
WGP. Arterial blood pressure slightly increased during 
the experiment in all groups. However a similar trend in 
the increase of arterial blood pressure was observed in all 
three rats (Fig. 1).
WGP prevented the rise of glucose and the area under the 
curve on the glucose tolerance test in fructose‑fed rats
Rats treated with a high fructose diet had the high-
est fasting level of blood glucose, before beginning the 
GTT (Fig. 2a). The GTT showed that the largest increase 
in blood glucose measured at 30 min and 2 h following 
glucose administration was observed in the HF group. 
In addition, it is worth to note that glucose levels in the 
HF +  WGP group were slightly lower than the one on 
the control group, while the lowest curve was from the 
C + WGP group. To quantify these differences, we meas-
ured the area under curve (AUC) of the glucose tolerance 
test (Fig. 2b). We found a significant increase in the area 
under the curve in the HF fed group, whereas WGP pre-
vented the increased AUC in the WGP + HF treated rats.
WGP prevented the induction of insulin resistance 
in fructose‑fed rats
To evaluate whether the increase in the AUC corre-
lates with the insulin concentration, we measured insu-
lin in the blood obtained after 12 h of starvation. Under 
these conditions, we found that rats from the HF fed 
group presented the highest levels of insulin, and its 
increase was prevented by the supplementation with 
WGP in the diet, as observed from the HF + WGP fed 
group (Fig.  3a). In addition, glucose levels were meas-
ured in these same blood samples and the homeostasis 
model assessment-estimated IR (HOMA-IR) index was 
Table 3 Physiological parameters of rats fed experimental diets
n = 6–8 in each group
C control diet, C + WGP control diet plus wine grape powder, HF high fructose diet, HF + WGP high fructose diet plus wine grape powder
* P < 0.05 Bonferroni after one way ANOVA
C C + WGP HF HF + WGP
Glucose in plasma (mg/dL) 94.8 ± 1.8 88.3 ± 3.0 104.3 ± 2.8* 91. ± 2.84
Triglycerides in plasma (mg/mL) 92.4 ± 6.8 108.8 ± 4.2 140.7 ± 11.2* 122.1 ± 7.8
Insulin in plasma (μU/mL) 7.6 ± 1.5 5.8 ± 0.6 912.2 ± 1.3* 8.9 ± 0.7
Systolic arterial pressure (mmHg) 108.8 ± 4.4 110.6 ± 2.1 115.0 ± 1.7 112.2 ± 1.8
Body weight (g) 515.8 ± 22.6 519.1 ± 17.9 514.0 ± 22.4 528.9 ± 21.8
Heart weight (g) 1.43 ± 0.05 1.46 ± 0.06 1.50 ± 0.05 1.56 ± 0.09
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evaluated for each group. HF fed rats presented a signifi-
cantly higher HOMA-IR index compared to control rats. 
In addition, this increase was prevented in HF +  WGP 
fed rats (Fig. 3b).
WGP prevented the rise of TBARS in plasma 
from fructose‑fed rats
High fructose diet produced a significant threefold 
increase in plasma TBARS levels measured at the end of 
16 weeks of treatment (Fig. 4). WGP effectively prevented 
this increase in TBARS levels in high fructose-fed rats. 
When compared to control, TBARS levels in HF + WGP 
were not significantly different from those of control rats.
WGP prevented the reduction of SOD protein levels 
in kidneys from fructose‑fed rats
Nrf-2 is considered a key transcription factor in the cel-
lular response to oxidative stress [31]. This transcription 
factor regulates the expression of several antioxidant 
enzymes that participate in the defense against reactive 
oxygen species such as superoxide dismutase (SOD). 
Therefore, we evaluated the effect of HF treatment on 
Nrf-2 levels in renal tissue and found no significant 
changes after 16  weeks of treatment in this transcrip-
tion factor. Although Nrf-2 protein levels were not sig-
nificantly modified by the diet, we speculated that its 
activity could be modified. For this reason, we measured 
mSOD protein concentration, one of the proteins regu-
lated by Nrf-2. We found a significant reduction in renal 
mSOD levels. Consistent with the previous observations, 
this decrease was not observed in HF rats fed with WGP 
(Fig. 5).
WGP prevents the rise of TBARS in kidneys 
from fructose‑fed rats
To determine whether the changes in mSOD proteins 
levels correlated with the oxidative state found in the 
kidney, we measured TBARS in renal tissue. We found a 
significant increase in TBARS in the HF group, whereas 
this increase was prevented in the HF + WGP fed group 
(Fig. 6).
Discussion
The main finding of the current study is that 16 weeks of 
supplementation with WGP protects against fructose-
induced oxidative stress and glucose intolerance in a rat 
model of metabolic syndrome. The metabolic syndrome 
is a growing health problem and it is important to find a 
Fig. 1 Arterial blood pressure measured by radiotelemetry in three 
conscious rats fed with control (C filled circle), high fructose (HF filled 
square) and high fructose + WGP (HF + WGP unfilled square) diets. 
Systolic and diastolic arterial blood pressure of the rats was displayed 
in the upper and lower part of the figure, respectively. Telemeters were 
implanted into the femoral artery and the recordings started 7 days 
after the surgery. Arrow indicate the beginning of the diet treatments
Fig. 2 WGP prevents the increase in the area under the curve for the glucose tolerance test. a Glucose tolerance test curves are shown for control 
(C filled circle), control + WGP (C + WGP unfilled circle) high fructose (HF filled square) and high fructose + WGP (HF + WGP unfilled square) fed ani‑
mals. Each curve represents mean ± SEM for at least six animals. b Area under the curve was calculated for the curve of each animal. Bars represent 
mean ± SEM for n = 6–8 rats in each group. *P < 0.05 HF vs. other groups. Bonferroni after one way ANOVA
Page 6 of 9Hernández‑Salinas et al. Biol Res  (2015) 48:53 
treatment to prevent its development. However, it is dif-
ficult to find a single treatment, because of the multiple 
factors that participate in this syndrome. The use of food 
supplements is one of the possible approaches to prevent 
the progression of this syndrome. The presented results 
show that WGP supplement prevents the evolution of the 
metabolic syndrome in rats.
Despite that arterial blood pressure did not change, we 
found that the high-fructose diet produced metabolic 
alterations similar to those found by others [23–26, 32]. 
Some studies have reported an increase in body weight 
[23] and arterial blood pressure [24] in rats treated with a 
high fructose diet, but other studies failed to find changes 
in these variables in Sprague–Dawley rats [25, 26]. The 
difference with other studies may reflect a differential 
response to stress of different strain rats, or the methods 
to measure arterial blood pressure. However, we meas-
ured arterial blood pressure in conscious rats using both 
radiotelemetry and the tail cuff methods. Several studies 
have demonstrated the ability of a high fructose diet to 
induce insulin resistance, reproducing the features of the 
metabolic syndrome in laboratory rats [23–26, 32]. Sim-
ilarly to other studies, we found an increase of the area 
Fig. 3 WGP prevents insulin resistance in HF fed rats. a Insulin was measured using a radioimmunoassay in control (C), control + WGP (C + WGP) 
high fructose (HF) and high fructose + WGP (HF + WGP) fed animals. b HOMA was calculated from insulin values shown in this figure and glucose 
values obtained at the same time points. Bars represent mean ± SEM for n = 6–8 rats in each group. *P < 0.05 HF vs. other groups. Bonferroni after 
one way ANOVA
Fig. 4 WGP reduces oxidative stress in HF fed rats. TBARS were 
measured in plasma from control (C), control + WGP (C + WGP) 
high fructose (HF) and high fructose + WGP (HF + WGP) diets. Bars 
represent mean ± SEM for n = 6–8 rats in each group. *P < 0.05 HF 
vs. other groups. Bonferroni after one way ANOVA
Fig. 5 WGP prevents the reduction in renal mSOD protein levels. 
Protein extracts from kidneys from control (C), control + WGP 
(C + WGP) high fructose (HF) and high fructose + WGP (HF + WGP) 
fed animals were used to evaluate mSOD protein levels. Bars repre‑
sent mean ± SEM for n = 4 animals in each group. Bars represent 
mean ± SEM for n = 4, *p < 0.05 HF vs. other groups. Bonferroni after 
one way ANOVA. Representative blots for mSOD and β‑actin used as 
loading control are shown under the graph
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under curve of the glucose tolerance test, fasting blood 
glucose, plasma insulin, the HOMA index, and TBARS in 
plasma and renal tissue of HF-fed rats [23–26, 32].
It has been observed that high fructose fed rats develop 
metabolic syndrome without requiring an increased 
energy intake, because fructose is metabolized differ-
ent than glucose ultimately producing uric acid. Uric 
acid is an antioxidant in the extracellular environment, 
but when enters the cells it induces an oxidative burst, 
mediated by the NADPH oxidase. This burst can induce 
increases in arterial blood pressure when affecting 
endothelial cells and in body weight. One explanation to 
the absence of effect on body weight and arterial pressure 
in our model is that in rats, uricase is expressed in high 
amounts so there is an efficient degradation of uric acid. 
Nevertheless, it has been reported that fructose induces 
insulin resistance even with high levels of uricase [33], 
and although we did not measure uricase, we did observe 
insulin resistance in our experimental group.
Oxidative stress is a feature of several metabolic disor-
ders. Kunde et  al. [34] evaluated the oxidative stress in 
the liver of mice exposed to 30 % fructose diet, and found 
an increase in TBARS, which did not reach significance. 
Similarly, Yin et  al. [35] found that TBARS increased 
in the hippocampus and cerebral cortex in Wistar rats 
treated with 10  % fructose from 16  weeks. Moreover, 
they demonstrated that these changes were prevented by 
the administration of Pioglitazone, an antihyperglycemic 
drug. We found an increase in renal TBARS that corre-
lates with the decrease in the levels of mSOD. The abil-
ity of WGP to prevent the increases in TBARS and the 
decreases in mSOD levels, suggests that WGP may be as 
effective as some pharmacological drugs in preventing 
the alterations induced by fructose.
The effects of WGP on oxidative stress and glucose 
intolerance found in this study could be attributed to 
its high content in polyphenols. These compounds are 
found in all plant species. They are important in plants 
for reproduction, growth, pigmentation and protec-
tion against pathogens [36]. Polyphenols are abundant 
in the mediterranean diet that is rich in fruits and wine. 
Grapes contain a great variety of polyphenols, including 
resveratrol, flavonoids, flavonols, flavones and anthocya-
nines. Polyphenols can exert several effects. It has been 
postulated that polyphenols from green tea, may reduce 
cholesterol and fatty acid absorption [37]. In addition, 
it was shown that a lyophilized grape powder reduced 
the overall metabolism of lipoproteins [38]. Patel et  al. 
[39] showed that dietary polyphenols may attenuate the 
inflammation through modulation of the activities of 
NF-κB and Nrf-2.
When evaluating one particular polyphenol, it has 
been reported that resveratrol, extracted from grape 
skins, increases the activity of SIRT1 [40] and AMPK 
[41], and inhibits the mitochondrial ATP synthase [42]. 
On the other hand, EGCG has been used to inhibit sev-
eral receptor tyrosine kinase activities such as the ones 
from vascular endothelial growth factor receptor [43] 
and insulin like growth factor receptor [44]. All together 
these results suggest that one or the combination of the 
different polyphenols found in WGP may produce the 
beneficial effects observed in the rats treated with HF 
and WGP on this study.
Conclusions
In summary, the present results show that WGP sup-
plementation prevents glucose intolerance and reduces 
oxidative stress in rats fed with high fructose diet. 
Accordingly, WGP could be used as a food supplement 
for the prevention of the metabolic syndrome in human. 
Nevertheless, further studies are needed to validate the 
use of this flour in humans.
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